Y-Intercept (HK)’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.16M | Buy |
23,547
+22,745
| +2,836% | +$8.85M | 0.22% | 83 |
|
|
2025
Q1 | $349K | Sell |
802
-12,339
| -94% | -$5.37M | 0.02% | 851 |
|
|
2024
Q4 | $4.85M | Buy |
+13,141
| New | +$4.85M | 0.32% | 54 |
|
|
2024
Q3 | – | Sell |
-5,085
| Closed | -$2.76M | – | 1444 |
|
|
2024
Q2 | $2.76M | Buy |
5,085
+207
| +4% | +$112K | 0.15% | 165 |
|
|
2024
Q1 | $2.53M | Buy |
4,878
+2,117
| +77% | +$1.1M | 0.19% | 123 |
|
|
2023
Q4 | $1.3M | Sell |
2,761
-1,947
| -41% | -$918K | 0.12% | 227 |
|
|
2023
Q3 | $2.05M | Sell |
4,708
-791
| -14% | -$344K | 0.2% | 134 |
|
|
2023
Q2 | $2.44M | Buy |
+5,499
| New | +$2.44M | 0.26% | 82 |
|
|
2022
Q3 | – | Sell |
-3,882
| Closed | -$1.87M | – | 1055 |
|
|
2022
Q2 | $1.87M | Buy |
+3,882
| New | +$1.87M | 0.25% | 95 |
|
|
2021
Q3 | – | Sell |
-1,024
| Closed | -$391K | – | 715 |
|
|
2021
Q2 | $391K | Buy |
+1,024
| New | +$391K | 0.1% | 332 |
|